First Page | Document Content | |
---|---|---|
![]() Date: 2006-05-12 01:26:58Pharmaceutical industry Quarters of Monaco Monte Carlo Generic drug Food and Drug Administration Monaco Bioequivalence Abbreviated New Drug Application Authorized generics Pharmaceutical sciences Pharmaceuticals policy Pharmacology | Source URL: www.gpaconferences.comDownload Document from Source WebsiteFile Size: 855,21 KBShare Document on Facebook |
![]() | PDF DocumentDocID: 17rqt - View Document |
![]() | THE MACKAY REPORT BRANDS & GENERICS SEPTEMBER[removed]MACKAY RESEARCHDocID: WrLN - View Document |
![]() | \\server05\productn\C\COL\108-6\COL604.txt unknown Seq: 1DocID: RORi - View Document |
![]() | Analysis Brief Generic Drugs in Canada, 2013 sets a potentially useful benchmark for Canadian generic price levels prior to the full implementation of the Value Price Initiative, which will take place by April 1, 2016.DocID: MjQv - View Document |
![]() | Lamictal brief April28 finalDocID: DDOO - View Document |